Driven by the increasing prevalence of diabetes, diabetic macular edema (DME) is becoming an increasing concern for ophthalmologists around the globe and particularly in the United Arab Emirates (UAE).

These guidelines provide treatment recommendations for both center-involving and non-center-involving DME, including the use of anti-vascular endothelial growth factor (VEGF) injections, and the treatment of DME in special circumstances.

The aim of these guidelines on the management of DME is to continuously advance the standard of ophthalmology practice in the UAE, in order to improve eye and visual health in the UAE community and beyond.